Bibliografía del artículo
1. Billiard M. Diagnosis of narcolepsy and idiopathic hypersomnia. An update based on the International classification of sleep disorders, 2nd edition. Sleep Med Rev 11(5):377-88, 2007.
2. Littner MR, Kushida C, Wise M, et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 28(1):113-21, 2005.
3. Rechtschaffen A, Dement W. Studies on the relation of narcolepsy, cataplexy, and sleep with low voltage random EEG activity. Res Publ Assoc Res Nerv Ment Dis 45:488-505, 1967.
4. Dean RR, Kilduff TS, Dement WC, Grumet FC. Narcolepsy without unique MHC class II antigen association: studies in the canine model. Hum Immunol 25(1):27-35, 1989.
5. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6(9):991-7, 2000.
6. Lim AS, Scammell TE. The trouble with Tribbles: do antibodies against TRIB2 cause narcolepsy? Sleep 33(7):857-8, 2010.
7. Hallmayer J, Faraco J, Lin L, et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet 41(6):708-11, 2009.
8. Toyoda H, Tanaka S, Miyagawa T, Honda Y, Tokunaga K, Honda M. Anti-Tribbles homolog 2 autoantibodies in Japanese patients with narcolepsy. Sleep 33(7):875-8, 2010.
9. Coelho FM, Pradella-Hallinan M, Pedrazzoli M, et al. Traditional biomarkers in narcolepsy: experience of a Brazilian sleep centre. Arq Neuropsiquiatr 68(5):712-5, 2010.
10. Aloe F, Alves RC, Araujo JF, et al. [Brazilian guidelines for the treatment of narcolepsy]. Rev Bras Psiquiatr 32(3):305-14, 2010.
11. Coelho FM, Georgsson, H., Murray, J.M. Benefit of repeat multiple latency testing in confirming a possible narcolepsy diagnosis. J Clin Neuroph 28(4):412-4, 2011.
12. Marti I, Valko PO, Khatami R, Bassetti CL, Baumann CR. Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome. Sleep Med 10(10):1146-50, 2009.
13. Mignot E, Thorsby E. Narcolepsy and the HLA system. N Engl J Med 344(9):692, 2001.
14. Coelho FM, Pradella-Hallinan M, Predazzoli Neto M, Bittencourt LR, Tufik S. Prevalence of the HLA-DQB1*0602 allele in narcolepsy and idiopathic hypersomnia patients seen at a sleep disorders outpatient unit in São Paulo. Rev Bras Psiquiatr 31(1):10-4, 2009.
15. Goel N, Banks S, Mignot E, Dinges DF. DQB1*0602 predicts interindividual differences in physiologic sleep, sleepiness, and fatigue. Neurology 75(17):1509-19, 2010.
16. Lin L, Faraco J, Li R, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98(3):365-76, 1999.
17. Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27(3):469-74, 2000.
18. Mignot E. A commentary on the neurobiology of the hypocretin/orexin system. Neuropsychopharmacology 25(5 Suppl):S5-13, 2001.
19. Sutcliffe JG, de Lecea L. Novel neurotransmitters for sleep and energy homeostasis. Results Probl Cell Differ 26:239-55, 1999.
20. Nevsimalova S, Vankova J, Sonka K, et al. [Hypocretin (orexin) deficiency in narcolepsy-cataplexy]. Sb Lek 101(4):381-6, 2000.
21. Nishino S. Narcolepsy: pathophysiology and pharmacology. J Clin Psychiatry 68 Suppl 13:9-15, 2007.
22. Dauvilliers Y. [Neurodegenerative, autoimmune and genetic processes of human and animal narcolepsy]. Rev Neurol (Paris) 159(11 Suppl):6S83-7, 2003.
23. Dauvilliers Y, Montplaisir J, Cochen V, et al. Post-H1N1 narcolepsy-cataplexy. Sleep 33(11):1428-30, 2010.
24. Mignot E, Lin L, Rogers W, et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 68(3):686-99, 2001.
25. Broughton R, Valley V, Aguirre M, Roberts J, Suwalski W, Dunham W. Excessive daytime sleepiness and the pathophysiology of narcolepsy-cataplexy: a laboratory perspective. Sleep 9(1 Pt 2):205-15, 1986.
26. Knudsen S, Mikkelsen JD, Bang B, Gammeltoft S, Jennum PJ. Intravenous immunoglobulin treatment and screening for hypocretin neuron-specific autoantibodies in recent onset childhood narcolepsy with cataplexy. Neuropediatrics 41(5):217-22, 2010.
27. Coelho FM, Pradella-Hallinan M, Alves GR, Bittencourt LR, Tufik S. Report of two narcoleptic patients with remission of hypersomnolence following use of prednisone. Arq Neuropsiquiatr 65(2A):336-7, 2007.
28. Coelho FM, Pradella-Hallinan M, Pedrazzoli M, et al. Low CD40L levels and relative lymphopenia in narcoleptic patients. Hum Immunol 72(10):817-20, 2011.
29. Kawashima M, Lin L, Tanaka S, et al. Anti-Tribbles homolog 2 (TRIB2)
autoantibodies in narcolepsy are associated with recent onset of cataplexy. Sleep 33(7):869-74, 2010.
30. Billiard M, Bassetti C, Dauvilliers Y, et al. EFNS guidelines on management of narcolepsy. Eur J Neurol 13(10):1035-48, 2006.
31. Arnulf I, Mignot E. Sodium oxybate for excessive daytime sleepiness in narcolepsy-cataplexy. Sleep 27(7):1242-3, 2004.